Back to top
more

Veeva Systems (VEEV)

(Delayed Data from NYSE)

$281.46 USD

281.46
1,012,184

-3.82 (-1.34%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $281.46 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (71 out of 246)

Industry: Medical Info Systems

Zacks News

Zacks Equity Research

DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance

DXCM secures FDA clearance for its G7 15-Day CGM, the longest-lasting and most accurate wearable, enhancing user convenience and expanding diabetes care access.

Zacks Equity Research

Here's Why You Should Retain Ecolab Stock in Your Portfolio Now

ECL continues to gain from its robust product portfolio and strong segmental performance.

Zacks Equity Research

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks Equity Research

Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last?

Veeva (VEEV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Zacks Equity Research

Neogen Stock Tumbles on Q3 Earnings & Sales Miss, Margins Contract

NEOG posts lower-than-expected earnings and revenues for the third quarter of fiscal 2025.

Zacks Equity Research

Walgreens Beats on Q2 Earnings, Withdraws Fiscal 2025 View, Stock Down

WBA delivers better-than-expected earnings and revenues in the second quarter of fiscal 2025.

Zacks Equity Research

Is WisdomTree Cloud Computing ETF (WCLD) a Strong ETF Right Now?

Smart Beta ETF report for WCLD

Zacks Equity Research

Veeva Systems (VEEV) Gains As Market Dips: What You Should Know

In the latest trading session, Veeva Systems (VEEV) closed at $214.74, marking a +0.5% move from the previous day.

John Blank headshot

The First Q1 Earnings Land: Global Week Ahead

Global investors have yearned for clarity over President Trump's tariffs. But now they have it, and don't much like what they see.

Zacks Equity Research

Why Is Veeva (VEEV) Down 6.2% Since Last Earnings Report?

Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Zacks Equity Research

New Strong Buy Stocks for April 3rd

NATL, BGC, NPSNY, ALX and VEEV have been added to the Zacks Rank #1 (Strong Buy) List on April 3, 2025.

Zacks Equity Research

Best Momentum Stocks to Buy for April 3rd

VEEV, BNPQY and NECB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 3, 2025.

Zacks Equity Research

VEEV Stock Slips Despite New Research Site Clinical Trial System

Veeva introduces a Research Site Clinical Trial Management System to streamline trial operations, enhance collaboration, and accelerate clinical research efficiency.

Zacks Equity Research

Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It?

According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Zacks Equity Research

Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know

Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Nalak Das headshot

5 Momentum Stocks to Buy for April Despite a Disappointing March

Five stocks have strong momentum for April. These are: APP, MRVL, DOCS, RDDT, VEEV.

Panel Of Zacks Experts headshot

Top Stock Picks for Week of March 31, 2025

A medical info systems stock with a positive earnings ESP and a civil engineering company with upbeat estimate changes.

Zacks Equity Research

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks Equity Research

Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth Today

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Zacks Equity Research

Should You Invest in the WisdomTree Cloud Computing ETF (WCLD)?

Sector ETF report for WCLD

Zacks Equity Research

Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It

Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Equity Research

Veeva (VEEV) Is Considered a Good Investment by Brokers: Is That True?

The average brokerage recommendation (ABR) for Veeva (VEEV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks Equity Research

Best Momentum Stock to Buy for March 17th

PSO, VEEV and PAA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 17, 2025.

Zacks Equity Research

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.